150 related articles for article (PubMed ID: 27760926)
21. Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.
Felmlee DJ; Hafirassou ML; Lefevre M; Baumert TF; Schuster C
Viruses; 2013 May; 5(5):1292-324. PubMed ID: 23698400
[TBL] [Abstract][Full Text] [Related]
22. TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.
Boyer A; Park SB; de Boer YS; Li Q; Liang TJ
Gastroenterology; 2018 Dec; 155(6):1923-1935.e8. PubMed ID: 30144428
[TBL] [Abstract][Full Text] [Related]
23. HCV and host lipids: an intimate connection.
Schaefer EA; Chung RT
Semin Liver Dis; 2013 Nov; 33(4):358-68. PubMed ID: 24222093
[TBL] [Abstract][Full Text] [Related]
24. HCV Interplay with Lipoproteins: Inside or Outside the Cells?
Cosset FL; Mialon C; Boson B; Granier C; Denolly S
Viruses; 2020 Apr; 12(4):. PubMed ID: 32290553
[TBL] [Abstract][Full Text] [Related]
25. A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.
Tao W; Xu C; Ding Q; Li R; Xiang Y; Chung J; Zhong J
Virology; 2009 Dec; 395(1):67-76. PubMed ID: 19793603
[TBL] [Abstract][Full Text] [Related]
26. Arylacetamide deacetylase: a novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production.
Nourbakhsh M; Douglas DN; Pu CH; Lewis JT; Kawahara T; Lisboa LF; Wei E; Asthana S; Quiroga AD; Law LM; Chen C; Addison WR; Nelson R; Houghton M; Lehner R; Kneteman NM
J Hepatol; 2013 Aug; 59(2):336-43. PubMed ID: 23542347
[TBL] [Abstract][Full Text] [Related]
27. Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses.
Hueging K; Weller R; Doepke M; Vieyres G; Todt D; Wölk B; Vondran FW; Geffers R; Lauber C; Kaderali L; Penin F; Pietschmann T
PLoS One; 2015; 10(7):e0134529. PubMed ID: 26226615
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein component associated with hepatitis C virus is essential for virus infectivity.
Shimizu Y; Hishiki T; Ujino S; Sugiyama K; Funami K; Shimotohno K
Curr Opin Virol; 2011 Jul; 1(1):19-26. PubMed ID: 22440563
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus particles and lipoprotein metabolism.
André P; Perlemuter G; Budkowska A; Bréchot C; Lotteau V
Semin Liver Dis; 2005 Feb; 25(1):93-104. PubMed ID: 15732001
[TBL] [Abstract][Full Text] [Related]
30. Role of lipid metabolism in hepatitis C virus assembly and entry.
Popescu CI; Dubuisson J
Biol Cell; 2009 Oct; 102(1):63-74. PubMed ID: 19857204
[TBL] [Abstract][Full Text] [Related]
31. Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles.
Felmlee DJ; Sheridan DA; Bridge SH; Nielsen SU; Milne RW; Packard CJ; Caslake MJ; McLauchlan J; Toms GL; Neely RD; Bassendine MF
Gastroenterology; 2010 Nov; 139(5):1774-83, 1783.e1-6. PubMed ID: 20682323
[TBL] [Abstract][Full Text] [Related]
32. The mechanism of HCV entry into host cells.
Douam F; Lavillette D; Cosset FL
Prog Mol Biol Transl Sci; 2015; 129():63-107. PubMed ID: 25595801
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E, a Crucial Cellular Protein in the Lifecycle of Hepatitis Viruses.
Tréguier Y; Bull-Maurer A; Roingeard P
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409035
[TBL] [Abstract][Full Text] [Related]
34. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A
Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063
[TBL] [Abstract][Full Text] [Related]
35. [Advances in research on HCV replication and virion formation].
Suzuki T; Hara H; Aizaki H; Suzuki R; Masaki T
Uirusu; 2010 Jun; 60(1):87-92. PubMed ID: 20848868
[TBL] [Abstract][Full Text] [Related]
36. Unique ties between hepatitis C virus replication and intracellular lipids.
Herker E; Ott M
Trends Endocrinol Metab; 2011 Jun; 22(6):241-8. PubMed ID: 21497514
[TBL] [Abstract][Full Text] [Related]
37. Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success.
Steenbergen RH; Joyce MA; Lund G; Lewis J; Chen R; Barsby N; Douglas D; Zhu LF; Tyrrell DL; Kneteman NM
Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G844-54. PubMed ID: 20651006
[TBL] [Abstract][Full Text] [Related]
38. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
[TBL] [Abstract][Full Text] [Related]
39. Structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus.
Yamamoto M; Aizaki H; Fukasawa M; Teraoka T; Miyamura T; Wakita T; Suzuki T
J Gen Virol; 2011 Sep; 92(Pt 9):2082-2087. PubMed ID: 21593275
[TBL] [Abstract][Full Text] [Related]
40. Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.
Frentzen A; Anggakusuma ; Gürlevik E; Hueging K; Knocke S; Ginkel C; Brown RJ; Heim M; Dill MT; Kröger A; Kalinke U; Kaderali L; Kuehnel F; Pietschmann T
Hepatology; 2014 Jan; 59(1):78-88. PubMed ID: 23873628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
